Adaptive Biotechnologies Corporation
7 years in business
1551 Eastlake Ave E Ste 200
Seattle, WA 98102-7402
BBB File Opened: 09/20/2010
Business Started: 09/01/2009
Business Started Locally: 09/01/2009
Business Incorporated: 09/08/2009 in WA
Type of Entity
Mr. Chad Robins, CEO
Heather Craig, Business Office Mgr.
Laboratories - Research & Development
NAICS: Other Scientific and Technical Consulting Services
Products & Services
The company's core competency is developing next generation sequencing assays that characterize the adaptive immune system, serving as a platform technology to the research community and the biopharmaceutical industry. Its flagship commercial product, immunoSEQ (HTTP://WWW.IMMUNOSEQ.COM), uses a proprietary immune profiling assay to analyze T cells and B cells - critical components of the adaptive immune system's defense against disease - with unprecedented depth and specificity. Sequencing the variable region of these immune cells allows researchers to characterize the complete immune repertoire of a patient or group of patients in search of immunologic biomarkers. Fueled by discoveries from immunoSEQ, the company is currently developing a pipeline of clinical assays that are specific to cancer diagnosis and prognosis. All of Adaptive Biotechnologies' assays are coupled with a cloud-computing infrastructure that simplifies the interpretation of massive quantities of data in a user-friendly interface.
Licensing, Bonding or Registration
This business is in an industry that may require professional licensing, bonding or registration. BBB encourages you to check with the appropriate agency to be certain any requirements are currently being met.